tiprankstipranks

Xencor Appoints Todd Simpson to Board of Directors

Story Highlights
Xencor Appoints Todd Simpson to Board of Directors

An announcement from Xencor ( (XNCR) ) is now available.

On March 13, 2025, Xencor announced the appointment of Todd Simpson to its Board of Directors and Audit Committee. With over 40 years of experience in financial leadership roles, including as CFO at Seagen Inc., Simpson’s expertise is expected to enhance Xencor’s strategic and operational capabilities, potentially strengthening its position in the biopharmaceutical industry.

More about Xencor

Xencor is a clinical-stage biopharmaceutical company focused on developing engineered antibodies for treating cancer and autoimmune diseases. The company utilizes its XmAb® technology to create new therapeutic mechanisms, with over 20 candidates in clinical development and multiple marketed medicines through partnerships.

YTD Price Performance: -44.81%

Average Trading Volume: 624,053

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $947.7M

For detailed information about XNCR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App